IP Verse

Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders - EP3116534

PATENT ANALYSIS

Patent Details

Grant Date
May 29, 2019
Company
BAXALTA GMBH
Oppositions

OCTAPHARMA AG

More patents of Baxalta Gmbh

EP3064508

EP3521422

EP3277718

Want to monitor this patent?

Feel free to send us a message here and we will get back to you